Top Story This New Color for Sony’s WH-1000XM6 Headphones May Be My Favorite So Far CNET · tech 2h ago Read
Boeing's 737 MAX 7 Was Supposed to Be Flying in 2019. The FAA Certified It Monday. NASDAQ · markets 22m ago Read
Should You Buy Nvidia Stock Before Aug. 26? Here's What History Suggests. NASDAQ · markets 28m ago Read
SpaceX Earnings Live: SPCX First Public Results, Elon Musk Comments Bloomberg · technology 31m ago Read
Here's 1 High-Upside Cryptocurrency That Investors Keep Underestimating NASDAQ · markets 35m ago Read
Why Is Walmart Down Year to Date? This Is the Only Answer I Can Think Of. NASDAQ · markets 40m ago Read
Tuesday Sector Laggards: Hospital & Medical Practitioners, Oil & Gas Exploration & Production Stocks NASDAQ · markets 47m ago Read
Here's the Average Retirement Savings That People 75 and Older Have Left NASDAQ · markets 55m ago Read
Alexandria Real Estate Equities Q2 26 Earnings Conference Call At 2:00 PM ET NASDAQ · markets 56m ago Read
Griffin’s NYC Office Tower Set to Land $3.3 Billion Construction Loan Bloomberg · markets 1h ago Read
Apple Gears Up for September iPhone Launch With Retail Employee Lottery Bloomberg · technology 1h ago Read
Is United Parcel Service (UPS) the Best Dividend Stock in the Industrial Sector? NASDAQ · markets 1h ago Read
3 Magnificent Artificial Intelligence (AI) Stocks to Buy Right Now and Hold for the Next Decade NASDAQ · markets 1h ago Read
Stanley Druckenmiller Put 18% of His $3.4 Billion Portfolio in This One Stock. Is Natera a Buy? NASDAQ · markets 1h ago Read
Retirees: 3 High-Yielding Dividend Stocks to Buy for Long-Term Stability and Recurring Cash Flow NASDAQ · markets 2h ago Read
Amazon Crossed $3 Trillion for the First Time Monday. Another 31% Puts It in the $4 Trillion Club. NASDAQ · markets 2h ago Read
Coca-Cola and PepsiCo Both Saw the Health Trend Coming. Only One of Them Actually Got Ahead of It. NASDAQ · markets 2h ago Read
2 Unstoppable Growth ETFs Worth Buying and Holding Through Every Market Cycle NASDAQ · markets 2h ago Read
Moderna Starts Phase 1 Trial of Experimental Ebola Vaccine for Congo Outbreak Bloomberg · markets 3h ago Read
